Clinical Trial Update: Study of Cirmtuzumab and Paclitaxel for Metastatic or Locally Advanced, Unresectable Breast Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating cirmtuzumab in combination with paclitaxel for metastatic or locally advanced, unresectable breast cancer has completed with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Cirmtuzumab (cirmtuzumab)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Barbara Parker, MD | Conditions: Breast Neoplasms | Phase 1 | Status: COMPLETED | Results posted: 2025-08-07